The Krey Lab operates at the intersection of biochemistry, structural biology and immunology. One of the group’s primary research interests is the design and optimisation of effective next-generation vaccines against major human pathogens, including hepatitis C virus (HCV), hepatitis E virus (HEV), human cytomegalovirus (HCMV) and other pathogenic viruses.
This research forms part of the University of Lübeck ’s human medicine-centred Life Sciences (STEM) programme in the field of infection biology. The laboratory bridges fundamental biochemical research (protein folding, structure and stability, protein-protein interactions, and the biochemistry of immune responses) with translational medicine (vaccine development), thereby contributing to the University of Lübeck’s goal of advancing personalised, highly effective therapeutic interventions.